A total of 217 patients with DSM-IV depressive disorders ( 121 major and 96 minor ) and ACS were randomly assigned to receive escitalopram in flexible doses of 5-20 mg/d ( n = 108 ) or placebo ( n = 109 ) for 24 weeks .